Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-03-23

Clinical Trial Update: A Study to Evaluate a Possible Superiority Expressed by the Faster Onset of Action and the Efficacy and Safety of Sildenafil Citrate 20mg Sublingual Tablet in the Treatment of Erectile Dysfunction of Different Etiologies [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating sildenafil citrate 20 mg sublingual tablets for erectile dysfunction from different etiologies to assess faster onset of actio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sildenafil Citrate Sublingual Tablet 20 mg (sildenafil citrate)

Snippet

Sponsor: Laboratório Teuto Brasileiro S/A | Conditions: Erectile Dysfunction | Phase 3 | Status: UNKNOWN